FDA NDC Directory · JSON-LD · Markdown

Rivastigmine

NDC 0378-9070 · HUMAN PRESCRIPTION DRUG · PATCH

Generic namerivastigmine
Labeler / ManufacturerMylan Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA205622
Dosage form / routePATCH · TRANSDERMAL
Active ingredientsRIVASTIGMINE (4.6 mg/24h)
Marketing started20180620
Package count1

External sources

Source: openFDA. Public-domain (CC0).